DE69534419D1 - Intrazelluläre isoform von interleukin-1 rezeptor antagonist - Google Patents
Intrazelluläre isoform von interleukin-1 rezeptor antagonistInfo
- Publication number
- DE69534419D1 DE69534419D1 DE69534419T DE69534419T DE69534419D1 DE 69534419 D1 DE69534419 D1 DE 69534419D1 DE 69534419 T DE69534419 T DE 69534419T DE 69534419 T DE69534419 T DE 69534419T DE 69534419 D1 DE69534419 D1 DE 69534419D1
- Authority
- DE
- Germany
- Prior art keywords
- interleukin
- antagonist
- intra
- receptor antagonist
- cellular isoform
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Toxicology (AREA)
- Communicable Diseases (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Transplantation (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cell Biology (AREA)
- Diabetes (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITMI942097A IT1270662B (it) | 1994-10-13 | 1994-10-13 | Antagonista della interleuchina-1 |
PCT/EP1995/004023 WO1996012022A1 (en) | 1994-10-13 | 1995-10-12 | Intracellular isoform of the interleukin-1 receptor antagonist |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69534419D1 true DE69534419D1 (de) | 2005-10-06 |
DE69534419T2 DE69534419T2 (de) | 2006-06-14 |
Family
ID=11369705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69534419T Expired - Fee Related DE69534419T2 (de) | 1994-10-13 | 1995-10-12 | Intrazelluläre isoform von interleukin-1 rezeptor antagonist |
Country Status (19)
Country | Link |
---|---|
US (1) | US5739282A (de) |
EP (1) | EP0786002B1 (de) |
JP (1) | JPH10509306A (de) |
KR (1) | KR100237936B1 (de) |
CN (2) | CN100363053C (de) |
AT (1) | ATE303439T1 (de) |
BR (1) | BR9509317A (de) |
CA (1) | CA2202470C (de) |
DE (1) | DE69534419T2 (de) |
EE (1) | EE03697B1 (de) |
ES (1) | ES2243942T3 (de) |
HK (2) | HK1002659A1 (de) |
IT (1) | IT1270662B (de) |
MX (1) | MX9702616A (de) |
NO (1) | NO320494B1 (de) |
PT (1) | PT786002E (de) |
RU (1) | RU2193064C2 (de) |
UA (1) | UA65522C2 (de) |
WO (1) | WO1996012022A1 (de) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5075222A (en) * | 1988-05-27 | 1991-12-24 | Synergen, Inc. | Interleukin-1 inhibitors |
US5872095A (en) * | 1990-05-01 | 1999-02-16 | Chiron Corporation | IL-1 receptor antagonists medicaments |
PT938500E (pt) | 1996-10-31 | 2005-02-28 | Applied Research Systems | Peptidos inibidores da ice |
DE69738948D1 (de) * | 1996-12-06 | 2008-10-09 | Amgen Inc | Il-1-inhibitor in kombinationstherapie zur behandlung il-1-vermittelter krankheiten |
US6294170B1 (en) | 1997-08-08 | 2001-09-25 | Amgen Inc. | Composition and method for treating inflammatory diseases |
IL126562A0 (en) * | 1998-10-14 | 1999-08-17 | Interpharm Lab Ltd | Expression and secretion of icil-1 receptor antagonist type ii |
US20020077276A1 (en) * | 1999-04-27 | 2002-06-20 | Fredeking Terry M. | Compositions and methods for treating hemorrhagic virus infections and other disorders |
US7166712B2 (en) * | 2000-07-12 | 2007-01-23 | Philadelphia, Health And Education Corporation | Mammalian MDM2 binding proteins and uses thereof |
ES2533084T3 (es) * | 2003-12-23 | 2015-04-07 | Genentech, Inc. | Tratamiento del cáncer con anticuerpos monoclonales anti-IL 13 novedosos |
EP2327413A1 (de) | 2004-07-06 | 2011-06-01 | ZymoGenetics, Inc. | Pharmazeutische Zusammensetzung enthaltend FGF-18 und einen IL-1 antagonisten sowie Verfahren zur Verwendung derselben |
WO2009062339A1 (en) | 2007-11-14 | 2009-05-22 | General Regeneratives, Ltd. | Methods of using interleukin-1 receptor antagonist as a myeloprotective agent |
CN101690801B (zh) | 2009-10-26 | 2012-08-01 | 上海交通大学 | 白细胞介素-1受体拮抗剂的用途及其药物组合物 |
CA2828504A1 (en) | 2011-03-14 | 2012-09-20 | Serodus Asa | Antagonists of the interleukin-1 receptor |
DK2859015T3 (en) | 2012-06-08 | 2018-06-18 | Alkermes Inc | LIGANDS MODIFIED BY CIRCULAR MODIFICATION AS AGONISTS AND ANTAGONISTS |
WO2015191783A2 (en) | 2014-06-10 | 2015-12-17 | Abbvie Inc. | Biomarkers for inflammatory disease and methods of using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR0148009B1 (ko) * | 1988-05-27 | 1998-08-01 | 그래고리 비. 아보트 | 인터루킨-1 억제제 |
ES2103305T3 (es) * | 1989-11-29 | 1997-09-16 | Amgen Boulder Inc | Produccion de inhibidor de interleuquina-1 humana recombinada. |
AU649245B2 (en) * | 1990-04-02 | 1994-05-19 | Amgen, Inc. | Methods for treating interleukin-1 mediated diseases |
WO1991017184A1 (en) * | 1990-04-27 | 1991-11-14 | The Upjohn Company | Modified interleukin-1 inhibitors |
WO1991017249A1 (en) * | 1990-05-01 | 1991-11-14 | Cetus Corporation | Interleukin-1 antagonist and uses thereof |
-
1994
- 1994-10-13 IT ITMI942097A patent/IT1270662B/it active IP Right Grant
-
1995
- 1995-06-07 US US08/476,860 patent/US5739282A/en not_active Expired - Fee Related
- 1995-10-12 CN CNB200510053993XA patent/CN100363053C/zh not_active Expired - Fee Related
- 1995-10-12 RU RU97107461/13A patent/RU2193064C2/ru not_active IP Right Cessation
- 1995-10-12 CN CNB951956647A patent/CN1224707C/zh not_active Expired - Fee Related
- 1995-10-12 CA CA002202470A patent/CA2202470C/en not_active Expired - Fee Related
- 1995-10-12 PT PT95936482T patent/PT786002E/pt unknown
- 1995-10-12 KR KR1019970701931A patent/KR100237936B1/ko not_active IP Right Cessation
- 1995-10-12 EE EE9700090A patent/EE03697B1/xx not_active IP Right Cessation
- 1995-10-12 EP EP95936482A patent/EP0786002B1/de not_active Expired - Lifetime
- 1995-10-12 WO PCT/EP1995/004023 patent/WO1996012022A1/en active IP Right Grant
- 1995-10-12 DE DE69534419T patent/DE69534419T2/de not_active Expired - Fee Related
- 1995-10-12 BR BR9509317A patent/BR9509317A/pt not_active Application Discontinuation
- 1995-10-12 MX MX9702616A patent/MX9702616A/es not_active IP Right Cessation
- 1995-10-12 JP JP8512932A patent/JPH10509306A/ja active Pending
- 1995-10-12 ES ES95936482T patent/ES2243942T3/es not_active Expired - Lifetime
- 1995-10-12 AT AT95936482T patent/ATE303439T1/de not_active IP Right Cessation
- 1995-12-10 UA UA97052129A patent/UA65522C2/uk unknown
-
1997
- 1997-04-09 NO NO19971624A patent/NO320494B1/no not_active IP Right Cessation
-
1998
- 1998-02-27 HK HK98101565A patent/HK1002659A1/xx not_active IP Right Cessation
-
2006
- 2006-03-22 HK HK06103612A patent/HK1081124A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO971624D0 (no) | 1997-04-09 |
EE03697B1 (et) | 2002-04-15 |
EE9700090A (et) | 1997-10-15 |
NO971624L (no) | 1997-05-30 |
CA2202470A1 (en) | 1996-04-25 |
RU2193064C2 (ru) | 2002-11-20 |
BR9509317A (pt) | 1997-10-14 |
CN100363053C (zh) | 2008-01-23 |
EP0786002B1 (de) | 2005-08-31 |
IT1270662B (it) | 1997-05-07 |
ATE303439T1 (de) | 2005-09-15 |
KR970706391A (ko) | 1997-11-03 |
KR100237936B1 (ko) | 2000-01-15 |
AU701471B2 (en) | 1999-01-28 |
ITMI942097A0 (it) | 1994-10-13 |
DE69534419T2 (de) | 2006-06-14 |
WO1996012022A1 (en) | 1996-04-25 |
UA65522C2 (en) | 2004-04-15 |
MX9702616A (es) | 1998-04-30 |
CN1224707C (zh) | 2005-10-26 |
US5739282A (en) | 1998-04-14 |
ITMI942097A1 (it) | 1996-04-13 |
JPH10509306A (ja) | 1998-09-14 |
CN1679919A (zh) | 2005-10-12 |
EP0786002A1 (de) | 1997-07-30 |
CN1161058A (zh) | 1997-10-01 |
CA2202470C (en) | 2008-09-16 |
HK1002659A1 (en) | 1998-09-11 |
PT786002E (pt) | 2005-11-30 |
ES2243942T3 (es) | 2005-12-01 |
HK1081124A1 (en) | 2006-05-12 |
NO320494B1 (no) | 2005-12-12 |
AU3841795A (en) | 1996-05-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1081124A1 (en) | Intracellular isoform of the interleukin-1 receptor antagonist | |
PT735818E (pt) | Proteinas inflamatorias de macrofagos pim-3 pim-4 e pim-1y | |
FI963101A0 (fi) | Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut | |
ATE306549T1 (de) | C-c ckr-1, ein c-c chemokin rezeptor | |
FI960727A0 (fi) | Neurokiniiniantagonisteina käyttökelpoiset heterosyklit | |
FI935585A0 (fi) | Pyrrolopyrimidiner | |
TR199900318T2 (xx) | IL-8 resept�r antagonistleri. | |
IT8522587A0 (it) | Corpo per prove ad ultrasuoni. | |
DK0786004T3 (da) | Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase | |
IT8020274A0 (it) | Poltrona anatomica asimmetrica, particolarmente per uso odontoiatrico. | |
TR200103448T2 (tr) | IL-8 reseptör antagonistleri. | |
DE3574910D1 (de) | Geraet zur untersuchung von medien mittels ultraschall-echographie. | |
FR2653445B1 (fr) | Fragment d'adnc codant pour le gene du recepteur de l'interferon alpha et procede de preparation d'une proteine correspondante. | |
IT8820705A0 (it) | Procedimento di calibrazione numerica di installazione di radiologia e installazione di calibrazione numerica per la messa in opera del procedimento. | |
DK412286D0 (da) | 4-acylaminobenzamid-derivater, fremgangsmaade til fremstilling heraf samt mellemprodukter til brug ved fremgangsmaaden | |
DE3785175D1 (de) | A-assoziierte h-antigene, spezifische monoklonale antikoerper und methoden zu deren verwendung zur blutgruppenbestimmung. | |
IT8248390A0 (it) | N-[4-(3-amminopropil)amminobutil]2,2-diidrossiotanammide come immuno -stimolante ed intermedio per laproduzione di sostanze carcinostati che, e procedimento per la sua preparazione | |
IT8430790V0 (it) | Dispositivo orientabile per i comandi di movimento delle poltrone particolarmente per dentisti. | |
IT8430791V0 (it) | Dispositivo per la sincronizzazione dello schienale particolarmente per poltrone di dentisti. | |
IT210001Z2 (it) | Regolo calcolatore particolarmente ad uso medico. | |
IT8920060A0 (it) | Impianto per la riduzione di pressione del gas metano tra le centrali di pompaggio e le reti di distribuzione all'utenza. | |
IT209196Z2 (it) | Struttura di corpo di contenimento per placchie, targhe e simili. | |
KR900020697U (ko) | 초음파 가습기의 진동자용 고무링 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: LABORATOIRES SERONO S.A., COINSINS, VAUD, CH |
|
8339 | Ceased/non-payment of the annual fee |